Citations

Showing 10 of 108135 citations.

Modulation of fracture healing by the transient accumulation of senescent cells
Saul, Dominik , Rowsey, Jennifer L. , Kosinsky, Robyn Laura , Vos, Stephanie J. B. , Farr, Joshua N. , Khosla, Sundeep , Vos, Stephanie J, Doolittle, Madison L. , Farr, Joshua N , Khosla, Sundeep , Kosinsky, Robyn Laura , Saul, Dominik , Monroe, David G. , Vos, Stephanie J

Mayo Clinic

eLife | October 7, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.7554/elife.69958 | PMID 34617510 Get It

Senescent cells have detrimental effects across tissues with aging but may have beneficial effects on tissue repair, specifically on skin wound healing. However, the potential role of senescent cells in fracture healing has not been defined. Here, we performed an in silico analysis of public mRNAseq data and found that senescence and senescence-associated secretory phenotype (SASP) markers increased during fracture healing. We next directly established that the expression of senescence biomarkers increased markedly during murine fracture healing. We also identified cells in the fracture callus that displayed hallmarks of senescence, including distension of satellite heterochromatin and telomeric DNA damage; the specific identity of these cells, however, requires further characterization. Then, using a genetic mouse model ( Cdkn2a LUC ) containing a Cdkn2a Ink4a -driven luciferase reporter, we demonstrated transient in vivo senescent cell accumulation during callus formation. Finally, we intermittently treated young adult mice following fracture with drugs that selectively eliminate senescent cells (‘senolytics’, Dasatinib plus Quercetin), and showed that this regimen both decreased senescence and SASP markers in the fracture callus and significantly accelerated the time course of fracture healing. Our findings thus demonstrate that senescent cells accumulate transiently in the murine fracture callus and, in contrast to the skin, their clearance does not impair but rather improves fracture healing.
Technical Note: Long‐term monitoring of diode sensitivity degradation induced by proton irradiation
Younkin, James E. , Robertson, Daniel , Hu, Yanle , Morales, Danairis Hernandez, Shen, Jiajian , Ding, Xiaoning, Robertson, Daniel G, Bues, Martin , Shen, Jiajian , Liu, Wei

Mayo Clinic

Medical Physics | October 7, 2021 | Volume: 48 | Issue: 11 | Pages: 6634-6641

10.1002/mp.15265 | PMID 34608990 Get It

AbstractPurposeTo measure diode sensitivity degradation (DSD) induced by cumulative proton dose delivered to a commercial daily quality assurance (QA) device.MethodsAt our institution, six Daily QA 3 (DQA3, Sun Nuclear Corporation, Melbourne, FL, USA) devices have been used for daily proton pencil beam scanning QA in four proton gantry rooms over a span of 4 years. DQA3 diode counts were cross‐calibrated using a homogenous field with a known dose of 1 Gy. The DSD rate (ΔR%/100 Gy) was calculated using linear regression on time‐series plots of diode counts and an estimate of cumulative dose per year based on the cross‐calibration. The effect of DSD on daily QA spot position measurements was quantified by converting DSD to baseline spot position shift.ResultsThe average dose delivered to the four inner DQA3 diodes was 104 ± 5 Gy/year, and the rate of DSD was ‐5.1% ± 1.0/100 Gy with the exception of one DQA3 device that had a significantly higher rate of DSD (–12%/100 Gy). The R2s of the linear fit to time‐series plots were between 0.92 and 0.98. The DSD rates were not constant but decreases with accumulated doses. The four center diodes, which received 40% of the cumulative dose received by inner diodes, had a DSD rate of –7.2% ± 0.9/100 Gy. For our daily QA program, 1 year of DSD was equivalent to a 0.2 mm shift in spot position.ConclusionsThe DSD rate of DQA3 diodes determined by long‐term proton daily QA data was about –5%/100 Gy, which is more than 10 times greater than the reported DSD rate from photon irradiation. DQA3 diodes may be used for daily proton QA programs, provided that they are recalibrated at an appropriate frequency that should be determined specifically for different daily QA programs.
The Case for Palliative Reconstruction
Teven, Chad M., Lettieri, Salvatore C., Rebecca, Alanna M., Teven, Chad M., Lettieri, Salvatore C., Rebecca, Alanna M.

Mayo Clinic

Plastic & Reconstructive Surgery | October 6, 2021 | Volume: 148 | Issue: 5 | Pages: 868e-870e

10.1097/prs.0000000000008472 | PMID 34609984 Get It

A Call for a Formalized Plastic Surgery Medical Student Network: Increasing Exposure and Scholarly Opportunities Amid the Virtual Revolution
Antezana, Luis A. , Bakri, Karim , Antezana, Luis , Bakri, Karim

Mayo Clinic

Plastic & Reconstructive Surgery | October 6, 2021 | Volume: 148 | Issue: 5 | Pages: 870e-871e

10.1097/prs.0000000000008474 | PMID 34609992 Get It

Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners
Leiman, David A. , Freedberg, Daniel E. , Gyawali, C. Prakash , Gyawali, C P , Ravi, Karthik

Mayo Clinic

Journal of Clinical Gastroenterology | October 6, 2021 | Volume: 56 | Issue: 7 | Pages: 571-575

10.1097/mcg.0000000000001623 | PMID 34608025 Get It

Goals: The aim was to quantify proton pump inhibitor (PPI) practice habits among gastroenterology (GI) practitioners. Background: Reports of side effects have prompted patients and practitioners alike to discontinue PPI use. Emerging evidence-based literature on PPI risks and safety seek to guide practitioners, but the impact of this literature on PPI prescribing patterns has not been evaluated. Study: We performed an anonymous online survey of US GI practitioners across 6 academic and community affiliated medical centers. Demographic data including practice type and number of weekly gastroesophageal reflux disease patients seen were obtained. Survey questions evaluated practitioners’ monitoring for PPI side effects, dose adjustments, and sources of information about PPI risks. Results: The survey response rate was 60% (256/429). The majority of respondents were male (169, 66%) attending physicians (178, 70%) practicing general GI (63, 25%). There were 92 (36%) respondents who reported testing for PPI side effects at least once a year. Most respondents (143, 56%) reported discontinuing PPIs at least 50% of the time because of patients’ concerns about PPI side effects. The majority of respondents reported getting their information regarding PPI safety from published journals (239, 98%) as well as colleagues (222, 91%). Conclusions: Despite best available evidence suggesting safety of long-term PPI use without routine monitoring, stopping PPIs and monitoring for potential side effects occurs frequently, even within a cohort of mostly academic GI practitioners. Alternative strategies are needed to improve adherence to best practices, especially since gastroenterologists often serve as PPI experts.
Emerging approaches to improve allogeneic hematopoietic cell transplantation outcomes for nonmalignant diseases
DeFilipp, Zachariah , Chen, Yi‐Bin , Blazar, Bruce R. , Chen, Yi-Bin , Blazar, Bruce R , Hefazi, Mehrdad

Mayo Clinic

Blood | October 6, 2021 | Volume: 139 | Issue: 25 | Pages: 3583-3593

10.1182/blood.2020009014 | PMID 34614174 Get It

AbstractMany congenital or acquired nonmalignant diseases (NMDs) of the hematopoietic system can be potentially cured by allogeneic hematopoietic cell transplantation (HCT) with varying types of donor grafts, degrees of HLA matching, and intensity of conditioning regimens. Unique features that distinguish the use of allogeneic HCT in this population include higher rates of graft failure, immune-mediated cytopenias, and the potential to achieve long-term disease-free survival in a mixed chimerism state. Additionally, in contrast to patients with hematologic malignancies, a priority is to completely avoid graft-versus-host disease in patients with NMD because there is no theoretical beneficial graft-versus-leukemia effect that can accompany graft-versus-host responses. In this review, we discuss the current approach to each of these clinical issues and how emerging novel therapeutics hold promise to advance transplant care for patients with NMDs.
A High-Sensitivity International Knee Documentation Committee Survey Index From the PROMIS System: The Next-Generation Patient-Reported Outcome for a Knee Injury Population
Robins, Richard J. , Sheean, Andrew J. , Dekker, Travis J. , Collaborative, MOTION, Bailey, James R. , Bharmal, Husain, Bradley, Matthew W. , Cameron, Kenneth L. , Burns, Travis C. , Freedman, Brett A. , Grenier, Eric, Haley, Chad A., Hurvitz, Andrew P. , Mauntel, Timothy C. , McDonald, Lucas S. , Nesti, Leon J. , Posner, Matthew, Provencher, Matthew T. , Roach, Christopher J., Slabaugh, Mark A. , Tucker, Christopher J. , Volk, William R., Dickens, Jonathan F. , Dickens, Jonathan F , Tenan, Matthew S. , Collaborative, MOTION, Galvin, Joseph W. , LeClere, Lance E. , Lee, Ian , Owens, Brett D. , Potter, Benjamin Kyle , Rhon, Daniel I. , Ryan, Paul M. , Schmitz, Matthew R.

Mayo Clinic

The American Journal of Sports Medicine | October 6, 2021 | Volume: 49 | Issue: 13 | Pages: 3561-3568

10.1177/03635465211041593 | PMID 34612705 Get It

Background: Patient-reported outcomes (PROs) measure progression and quality of care. While legacy PROs such as the International Knee Documentation Committee (IKDC) survey are well-validated, a lengthy PRO creates a time burden on patients, decreasing adherence. In recent years, PROs such as the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function and Pain Interference surveys were developed as computer adaptive tests, reducing time to completion. Previous studies have examined correlation between legacy PROs and PROMIS; however, no studies have developed effective prediction models utilizing PROMIS to create an IKDC index. While the IKDC is the standard knee PRO, computer adaptive PROs offer numerous practical advantages. Purpose: To develop a nonlinear predictive model utilizing PROMIS Physical Function and Pain Interference to estimate IKDC survey scores and examine algorithm sensitivity and validity. Study Design: Cohort study (diagnosis); Level of evidence, 3. Methods: The MOTION (Military Orthopaedics Tracking Injuries and Outcomes Network) database is a prospectively collected repository of PROs and intraoperative variables. Patients undergoing knee surgery completed the IKDC and PROMIS surveys at varying time points. Nonlinear multivariable predictive models using Gaussian and beta distributions were created to establish an IKDC index score, which was then validated using leave-one-out techniques and minimal clinically important difference analysis. Results: A total of 1011 patients completed the IKDC and PROMIS Physical Function and Pain Interference, providing 1618 complete observations. The algorithms for the Gaussian and beta distribution were validated to predict the IKDC (Pearson = 0.84-0.86; R 2 = 0.71-0.74; root mean square error = 9.3-10.0). Conclusion: The publicly available predictive models can approximate the IKDC score. The results can be used to compare PROMIS Physical Function and Pain Interference against historical IKDC scores by creating an IKDC index score. Serial use of the IKDC index allows for a lower minimal clinically important difference than the conventional IKDC. PROMIS can be substituted to reduce patient burden, increase completion rates, and produce orthopaedic-specific survey analogs.
Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy
Simha, Vinaya , Dasari, Surendra , Klaus, Katherine A. , Brasseur, Nathan Le, Vučković, Ivan , LAURENTI, MARCELLO C. , Cobelli, Claudio , Le Brasseur, Nathan, Cobelli, Claudio , Vuckovic, Ivan , Lanza, Ian R. , Port, John D. , Nair, K. Sreekumaran

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 6, 2021 | Volume: 107 | Issue: 2 | Pages: 346-362

10.1210/clinem/dgab725 | PMID 34614176 Get It

Abstract Context Familial partial lipodystrophy (FPL), Dunnigan variety is characterized by skeletal muscle hypertrophy and insulin resistance besides fat loss from the extremities. The cause for the muscle hypertrophy and its functional consequences is not known. Objective To compare muscle strength and endurance, besides muscle protein synthesis rate between subjects with FPL and matched controls (n = 6 in each group). In addition, we studied skeletal muscle mitochondrial function and gene expression pattern to help understand the mechanisms for the observed differences. Methods Body composition by dual-energy X-ray absorptiometry, insulin sensitivity by minimal modelling, assessment of peak muscle strength and fatigue, skeletal muscle biopsy and calculation of muscle protein synthesis rate, mitochondrial respirometry, skeletal muscle transcriptome, proteome, and gene set enrichment analysis. Results Despite increased muscularity, FPL subjects did not demonstrate increased muscle strength but had earlier fatigue on chest press exercise. Decreased mitochondrial state 3 respiration in the presence of fatty acid substrate was noted, concurrent to elevated muscle lactate and decreased long-chain acylcarnitine. Based on gene transcriptome, there was significant downregulation of many critical metabolic pathways involved in mitochondrial biogenesis and function. Moreover, the overall pattern of gene expression was indicative of accelerated aging in FPL subjects. A lower muscle protein synthesis and downregulation of gene transcripts involved in muscle protein catabolism was observed. Conclusion Increased muscularity in FPL is not due to increased muscle protein synthesis and is likely due to reduced muscle protein degradation. Impaired mitochondrial function and altered gene expression likely explain the metabolic abnormalities and skeletal muscle dysfunction in FPL subjects.
Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein–Protein Complexes
Heyne, Michael , Shirian, Jason , Cohen, Itay , Papo, Niv , Shifman, Julia M. , Radisky, Evette S. , Papo, Niv , Shifman, Julia M , Peleg, Yoav

Mayo Clinic

Journal of the American Chemical Society | October 6, 2021 | Volume: 143 | Issue: 41 | Pages: 17261-17275

10.1021/jacs.1c08707 | PMID 34609866 Get It

Impact of Duration of Deafness on Speech Perception in Single-Sided Deafness Cochlear Implantation in Adults
Nassiri, Ashley M., Wallerius, Katherine P., Saoji, Aniket A., Neff, Brian A., Driscoll, Colin L. W., Carlson, Matthew L., Nassiri, Ashley M., Wallerius, Katherine P., Saoji, Aniket A., Neff, Brian A., Driscoll, Colin L. W., Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | October 6, 2021 | Volume: 43 | Issue: 1 | Pages: e45-e49

10.1097/mao.0000000000003357 | PMID 34889841 Get It

Objective: To evaluate the impact of prolonged auditory deprivation on speech perception outcomes in adult acquired single-sided deafness (SSD) cochlear implant (CI) recipients. Study Design: Retrospective case series. Setting: Tertiary care academic center. Patients: Acquired SSD in adults with and without prolonged duration of deafness (defined as >10 yr) who underwent CI between 2014 and 2019. Interventions: CI. Main Outcome Measures: Consonant-nucleus-consonant (CNC) and AzBio in quiet scores within first year of follow-up. Results: A total of 35 adult patients with SSD were evaluated, with a median overall duration of deafness of 2.4 years (interquartile range [IQR] 1.2–6.0 yr): seven patients with prolonged auditory deprivation (median 18 yr, IQR 15–28) were compared with 28 SSD patients with duration of deafness less than 10 years (median 1.7 yr, IQR 1.1–3.2). At last follow-up, the median CNC scores were 39% (IQR 31–64) and 54% (IQR 46–64) for the prolonged and shorter duration of deafness cohorts, respectively (p = 0.3). The median AzBio scores were 66% (IQR 65–68) and 72% (IQR 60–82) for the prolonged and shorter duration of deafness cohorts, respectively (p = 0.6). In a separate analysis evaluating duration of deafness as a continuous variable across all 35 patients, Spearman correlation coefficients for associations of duration of deafness with most recent CNC and AzBio scores were –0.02 (p = 0.9) and 0.02 (p = 0.9), respectively. Conclusions: Adult CI recipients with acquired SSD, with and without prolonged auditory deprivation, demonstrated comparable speech perception scores. Prolonged duration of deafness alone should not preclude a motivated SSD patient from undergoing cochlear implantation.